{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:35:04Z","timestamp":1790422504031,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Extramural venous invasion (EMVI) is a high-risk pathological feature in colorectal cancer, yet its role in guiding adjuvant chemotherapy in node-negative colon cancer remains uncertain. This study evaluates EMVI as a predictor of recurrence in patients undergoing colon cancer resection and investigates whether adjuvant chemotherapy affects recurrence in node-negative, EMVI-positive (N0\/EMVI\u2009+) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted on adults undergoing surgery for colon cancer at a single UK cancer centre between 2015 and 2022. Patients with rectal tumours or metastatic disease at presentation were excluded. Cox proportional hazards models were used to assess predictors of recurrence. Kaplan-Meier survival curves were generated to visualise recurrence-free survival (RFS) stratified by EMVI and chemotherapy status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 675 patients, EMVI was present in 361 (53%). EMVI was independently associated with increased recurrence (HR: 1.80, 95% CI: 1.14\u20132.84,\u00a0\n                      <jats:italic>p<\/jats:italic>\n                      =0.011). In the N0\/EMVI+ subgroup (\n                      <jats:italic>n<\/jats:italic>\n                      =124), chemotherapy was not significantly associated with reduced recurrence: partial chemotherapy (HR: 1.36, 95% CI: 0.30\u20136.20,\u00a0\n                      <jats:italic>p<\/jats:italic>\n                      =0.69), full chemotherapy (HR: 1.53, 95% CI: 0.46\u20135.12,\u00a0\n                      <jats:italic>p<\/jats:italic>\n                      =0.49). Kaplan-Meier analysis revealed five-year RFS of 80.9% for no chemotherapy, 60.6% for partial chemotherapy, and 41.6% for full chemotherapy (\n                      <jats:italic>p<\/jats:italic>\n                      =0.69). Survival differences were not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EMVI is a predictor of recurrence in patients undergoing surgery for colon cancer. However, in node-negative patients with EMVI, chemotherapy was not significantly associated with improved recurrence-free survival. These findings highlight the need for larger, prospective studies to better define the role of EMVI in guiding adjuvant therapy in stage II colon cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00384-026-05088-9","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:04:39Z","timestamp":1770786279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["EMVI as an independent predictor of recurrence and the role of chemotherapy in N0 colonic adenocarcinoma: retrospective Cox regression analysis (2015\u20132022)"],"prefix":"10.1007","volume":"41","author":[{"given":"S.","family":"Bhanderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"5088_CR1","unstructured":"World Health Organization. Colorectal Cancer [Internet]. World Health Organization. 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer. Accessed 05 Jun 2025"},{"issue":"1","key":"5088_CR2","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2025.108.1.39","volume":"108","author":"SH Hwang","year":"2025","unstructured":"Hwang SH, Shin SH, Kim YJ, Lee JH (2025) Risk factors for recurrence in stage I colorectal cancer after curative resection: a systematic review and meta-analysis. Ann Surg Treat Res 108(1). https:\/\/doi.org\/10.4174\/astr.2025.108.1.39","journal-title":"Ann Surg Treat Res"},{"issue":"3","key":"5088_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/SLA.0000000000000848","volume":"261","author":"M Chand","year":"2015","unstructured":"Chand M, Evans J, Swift RI et al (2015) The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg 261(3):473\u2013479. https:\/\/doi.org\/10.1097\/SLA.0000000000000848","journal-title":"Ann Surg"},{"issue":"7","key":"5088_CR4","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1245\/s10434-023-13225-9","volume":"30","author":"HM Thompson","year":"2023","unstructured":"Thompson HM et al (2023) MRI assessment of extramural venous invasion before and after total neoadjuvant therapy for locally advanced rectal cancer and its association with disease-free and overall survival. Ann Surg Oncol 30(7):3957\u20133965. https:\/\/doi.org\/10.1245\/s10434-023-13225-9","journal-title":"Ann Surg Oncol"},{"key":"5088_CR5","unstructured":"NICE. Recommendations | Colorectal cancer | Guidance | NICE [Internet]. www.nice.org.uk. 2020. https:\/\/www.nice.org.uk\/guidance\/ng151\/chapter\/Recommendations#management-of-local-disease. Accessed 05 Jun 2025"},{"issue":"10","key":"5088_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R et al (2020) Localised colon cancer: esmo clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(10):1291\u20131305. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.022","journal-title":"Ann Oncol"},{"issue":"3","key":"5088_CR7","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_438466","volume":"44","author":"P Pathak","year":"2024","unstructured":"Pathak P, Chan G, Deming D, Chee C (2024) State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation. Am Soc Clin Oncol Educ Book 44(3). https:\/\/doi.org\/10.1200\/EDBK_438466","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"5088_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1502014","volume":"15","author":"E Chen","year":"2025","unstructured":"Chen E, Chen L, Zhang W (2025) Robotic-assisted colorectal surgery in colorectal cancer management: a narrative review of clinical efficacy and multidisciplinary integration. Front Oncol 15. https:\/\/doi.org\/10.3389\/fonc.2025.1502014","journal-title":"Front Oncol"},{"issue":"1","key":"5088_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02306-2","volume":"19","author":"Q Pang","year":"2021","unstructured":"Pang Q, Duan L, Jiang Y, Liu H (2021) Oncologic and long-term outcomes of enhanced recovery after surgery in cancer surgeries - a systematic review. World J Surg Oncol 19(1). https:\/\/doi.org\/10.1186\/s12957-021-02306-2","journal-title":"World J Surg Oncol"},{"issue":"1","key":"5088_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33832","volume":"15","author":"SF Conroy","year":"2023","unstructured":"Conroy SF, Biddlestone LR, Courtney E (2023) Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes? Cureus 15(1). https:\/\/doi.org\/10.7759\/cureus.33832","journal-title":"Cureus"},{"issue":"7","key":"5088_CR11","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.ejso.2022.02.013","volume":"48","author":"PD McEntee","year":"2022","unstructured":"McEntee PD, Shokuhi P, Rogers AC et al (2022) Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death. Eur J Surg Oncol 48(7):1638\u20131642. https:\/\/doi.org\/10.1016\/j.ejso.2022.02.013","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"5088_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1308\/rcsann.2024.0038","volume":"106","author":"A Thrikandiyur","year":"2024","unstructured":"Thrikandiyur A, Kourounis G, Tingle S, Thambi P (2024) Robotic versus laparoscopic surgery for colorectal disease: a systematic review, meta-analysis and meta-regression of randomised controlled trials. Ann R Coll Surg Engl 106(8):658\u2013671. https:\/\/doi.org\/10.1308\/rcsann.2024.0038","journal-title":"Ann R Coll Surg Engl"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-026-05088-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-026-05088-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-026-05088-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:51:50Z","timestamp":1770789110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-026-05088-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5088"],"URL":"https:\/\/doi.org\/10.1007\/s00384-026-05088-9","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous communication"}}],"article-number":"64"}}